Home Meetings Online CME/CE Clinical Resources EHR/EMR

Southwest Annual Conference

Location: Houston, TX
Date: March 12-14, 2015

Meeting Overview

Venue:
George R. Brown Convention Center
Primary Audience:
Primary Care
Credits:
Earn up to 19.5 AMA PRA Category 1 Credits™ or 19.5 AANP contact hours

For those who look to you—you can look to us.

Primary care is where good health begins. It is based on your relationship with your patients as you provide and coordinate the care they need, from preventive health to specialty care to inpatient services. The demands and challenges you face every day within your practice are constantly changing, so we’re changing with them.

We’ve taken the feedback of last year’s attendees along with that of clinicians in your region and across the country to develop this year’s Annual Conference.

Download the conference brochure »

Already registered?
Download the onsite guide to prepare for the conference »

Pri-Med Southwest is closed.

Though registration is not yet open, Pri-Med Southwest will be back in Houston, TX in 2016. For a list of available 2015 conferences, please visit our website at Pri-Med.com.

View available 2015 conferences »

Earn up to 19.5 AMA PRA Category 1 Credits™ or 19.5 AANP contact hours of continuing education.

Quality CME

The entirely new, cutting-edge 2015 curriculum is developed by Pri-Med and its Medical Education Advisory Board, which includes members from the American College of Physicians and Baylor College of Medicine.

The CME sessions will include the latest treatments and therapies, such as:

  • Evidence-Based Guidelines for the Management of Hypertension
  • New Approaches to Treating C. difficile Infection
  • Update from The Medical Literature: News You Can Use
  • The Prostate: BPH and Beyond

How to register

Online:

Register

By Phone:

Call 844-300-6339

(Mon–Fri, 9am–8pm ET)

Register for Pri-Med Southwest by:

November 14 $55
January 9 $65
February 13 $75
March 11 $100
Onsite at Pri-Med Southwest $125

Value for Your Time

In addition to over 35 new educational sessions, there are many new components of the conference that were created with you in mind.

  • Renowned keynote speakers, including Dr. Sanjiv Chopra, presenting on “Dharma Happiness and Purpose” and Dean Ornish, MD, presenting “The Power of Lifestyle Changes, Social Networks, & Trust.”
  • Good Health Begins Here conference features, such as Steps to Success powered by Fitbit and Wellness Walks. Check out the Good Health tab for details.
  • The opportunity to attend Primary Care Updates pre-conference sessions and earn additional AMA PRA Category 1 Credits™ or AANP contact hours.

CME Activities

Primary Care Updates* | March 12, 2015
Earn up to 6.25 AMA PRA Category 1 Credits™ or 6.25 AANP contact hours of continuing education at these pre-conference sessions.

Annual Conference | March 13–14, 2015
Earn up to 13.25 AMA PRA Category 1 Credits™ or 13.25 AANP contact hours of continuing education during the core curriculum.


Educational Symposia
Accredited CME sessions to expand your learning during breaks from the core curriculum.

Credit Information

Industry-Sponsored Opportunities

Exhibit Hall
Have face-to-face conversations with industry professionals, gain helpful takeaways, and experience engaging floor activities such as live demonstrations, outside your office hours.

Presentation Theaters
Live discussions led by prominent medical thought leaders. Get an in-depth look at the latest tools and treatment options.

Presentation Theaters are not offered for CME credit nor is the content planned or reviewed by pmiCME or the ACP.

Learn More

*Primary Care Updates tracks are sponsored by pmiCME and are produced independently of and are not affiliated with the ACP. This is a limited-capacity ticketed event available during registration.

In accordance with the Americans with Disabilities Act, pmiCME seeks to make these conferences accessible to all. If you have a need that might require special accommodations, please call (877) 477-4633 or email support@pri-med.com three weeks prior to the meeting.

Sessions & Syllabus

For your convenience, we have printer-friendly syllabus slides available for you to download.

Print Primary Care Updates Syllabus

CLOSE  X  
Registration & Breakfast
CLOSE  X  
Registration & Breakfast
CLOSE  X  
Opening Remarks
CLOSE  X  
Opening Remarks
CLOSE  X  
New Drugs for PCP: What You Need to Know
Room: George Bush Ballroom, Level 3
Keeping up with the many new drugs approved for use in the US each year is a constant challenge. However only a small number of new drugs each year are novel, work by a new mechanism, and are relevant for primary care practice. This talk provides a balanced evaluation of these important novel drugs, and will address efficacy, side effects, cost, and the impact on primary care practice.
Learning Objectives:
  1. Review the pharmacological properties and modes of action of recently approved drugs
  2. Discuss the proper use of recently approved medications for their recommended disease states
  3. Compare the recently approved drugs to available therapies with respect to efficacy and cost effectiveness
Faculty:
  1. Gerald Smetana, MD, Clinician Educator, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical CenterBoston, MA, Professor of Medicine, Harvard Medical SchoolBoston, MA (Bio)
CLOSE  X  
Update on Immunizations in High Risk Adults
Room: Hall B3, Level 3
Learning Objectives:
  1. Identify profiles of specific patients at increased risk for vaccine-preventable diseases.
  2. Implement vaccine recommendations in high-risk patients.
  3. Recognize that health care provider recommendations are key to patient acceptance of vaccinations.
Faculty:
  1. M. Susan Burke, MD, FACP, Clinical Associate Professor, Sidney Kimmel Medical College, Thomas Jefferson UniversityPhiladelphia, PA, Senior Advisor, Lankenau Medical Associates, Lankenau Medical CenterWynnewood, PA (Bio)
  2. Barbara Yawn, MD, MSc, FAAFP, Director of Research, Olmsted Medical Center Rochester, MN, Adjunct Professor, Department of Family and Community Health, University of MinnesotaMinneapolis, MN (Bio)
CLOSE  X  
AM Break
CLOSE  X  
AM Break
CLOSE  X  
A Focus on Bipolar Depression: Overcoming Diagnostic Barriers and Optimizing Long-Term Patient Outcomes
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Discuss clinically relevant pathophysiology of bipolar disorder, including epidemiologic and mechanistic relationships with cardiometabolic disturbances.
  2. Identify patients with bipolar depression based on comprehensive patient histories, risk factors, key presenting symptoms, and the latest diagnostic criteria.
  3. Tailor therapeutic regimens for bipolar depression to reflect efficacy, safety, and tolerability of approved agents and common patient comorbidities.
  4. Engage patients with bipolar depression to motivate active participation in ongoing care and improve treatment adherence.
Faculty:
  1. Roger McIntyre, MD, FRCPC, Professor of Psychiatry and Pharmacology, University of TorontoToronto, ON, Head of Mood Disorders, Psychopharmacology Unit, University Health NetworkToronto, Ontario
  2. Joseph Calabrese, MD, Bipolar Disorders Research Chair, Professor, Department of Psychiatry, Director, Mood Disorders Program, University Hospitals Case Medical Center, Case Western Reserve University School of MedicineCleveland, OH
CLOSE  X  
Meeting The Challenge of Managing Lipids Beyond LDL-C
Room: Hall B3, Level 3
Learning Objectives:
  1. Discuss the role of elevated triglyceride levels and cardiovascular risk factors in the assessment and diagnosis of dyslipidemia.
  2. Apply best practices, including assessing fasting and non-fasting states, to accurately evaluate triglyceride levels.
  3. Use evidence-based practices and guidelines in managing hypertriglyceridemia to assess appropriate integration of new and emerging therapeutic approaches to manage TG-based dyslipidemia, mixed dyslipidemia, and associated cardiovascular risk.
Faculty:
  1. Peter Jones, MD, FACP, FNLA, Associate Professor, Methodist DeBakey Heart and Vascular Center, Baylor College of MedicineHouston, TX, Medical Director, Weight Management, Methodist Wellness Services, Co-Director, Lipid Metabolism and Atherosclerosis Clinic, The Methodist HospitalHouston, TX (Bio)
  2. Sergio Fazio, MD, PhD, The William and Sonja Connor Chair of Preventive Cardiology, Professor of Medicine, Director of Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health and Science UniversityPortland, OR (Bio)
CLOSE  X  
Getting Your Patients to Weigh In Discussing Approaches to Treating Obesity in the Primary Care Setting
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Summarize current recommendations for screening, assessment, and treatment goals in the management of adult obesity.
  2. Develop individualized therapeutic regimens for adults with obesity, incorporating lifestyle management and adjunct therapies as appropriate, based on current treatment recommendations and recent evidence.
  3. Utilize clinically validated approaches and tools to engage and support patients in the management of adult obesity as a chronic disease.
Faculty:
  1. Donna Ryan, MD, Professor Emerita, Pennington Biomedical Research CenterBaton Rouge, LA (Bio)
  2. Holly Wyatt, MD, Associate Professor of Medicine, Division of Endocrinology, Metabolism and Diabetes, Medical Director, The Wellness Clinic, Associate Director, Anschutz Health and Wellness Center, University of Colorado Denver, Anschutz Medical CampusAurora, CO (Bio)
CLOSE  X  
Evolving Insulin Therapy: Optimizing Care Through Proper Selection & Use
Room: Hall B3, Level 3
Learning Objectives:
  1. Implement strategies for the timely initiation of insulin therapy to best achieve glycemic control in patients with type 2 diabetes.
  2. Design insulin regimens that are appropriate and tailored to a patient’s specific needs.
  3. Recognize the barriers to insulin-mediated glucose control and apply strategies to overcome them.
  4. Outline the pharmacokinetic/pharmacodynamics profiles and evidence for emerging basal insulins for the treatment of type 2 diabetes.
Faculty:
  1. Jessica Castle, MD, Assistant Professor, Oregon Health & Science UniversityPortland, OR (Bio)
  2. Intekhab Ahmed, MD, FACE, FACP, Professor of Medicine, Thomas Jefferson UniversityPhiladelphia, PA (Bio)
CLOSE  X  
Lunch
CLOSE  X  
Lunch
CLOSE  X  
Optimizing the Diagnosis, Treatment, and Management of Irritable Bowel Syndrome
Room: Hall B3, Level 3
Learning Objectives:
  1. Diagnose IBS and differentiate from other bowel disorders using established clinical guidelines.
  2. Summarize the efficacy and safety of pharmacologic and nonpharmacologic treatment options for IBS.
  3. Implement patient-specific methods for managing IBS symptoms and improving function and quality of life.
Faculty:
  1. Spencer Dorn, MD, MPH, MHA, Vice Chief of Gastroenterology, Assistant Professor of Medicine, University of North Carolina Chapel Hill, NC (Bio)
  2. Brooks Cash, MD, Professor of Medicine, University of South AlabamaMobile, AL (Bio)
CLOSE  X  
Migraine Headaches: Tools for Successful Management
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Improve the identification of migraines in the patient with recurring headache and disability
  2. Apply the latest evidence-based recommendations for preventive and abortive migraine treatment
  3. Recommend complementary and alternative therapies when indicated
Faculty:
  1. M. Susan Burke, MD, FACP, Adjunct Associate Professor of Geriatrics, Philadelphia College of Osteopathic MedicinePhiladelphia, PA, Associate Professor of Medicine, Thomas Jefferson UniversityPhiladelphia, PA, Senior Advisor, Lankenau Medical Associates, Lankenau Medical CenterWynnewood, PA (Bio)
CLOSE  X  
PM Break
CLOSE  X  
PM Break
CLOSE  X  
Combining GLP-1 Receptor Agonists with Basal Insulin: Realizing the Potential in Type 2 Diabetes
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Implement ADA recommendations for A1C, fasting plasma glucose, and post-prandial glucose targets in the management of patients with type 2 diabetes.
  2. Assess the clinical profiles of GLP-1 receptor agonists and the advantages and disadvantages of prandial insulin.
  3. Describe the clinical rationale and expected benefits of using antidiabetic therapies with complementary mechanisms of action in the treatment of patients with type 2 diabetes.
  4. Utilize appropriate strategies to select and intensify antidiabetic therapy to achieve PPG control in patients with type 2 diabetes on basal insulin.
Faculty:
  1. Dace Trence, MD, FACE, Director, Diabetes Care CenterSalinas, CA, Professor, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, Director, Endocrine Fellowship Program, University of Washington Seattle, WA (Bio)
  2. Felice Caldarella, CDE , FACP , FACE, MD, Endocrinologist, Hunterdon Medical Center, Diabetes and Endocrine Associates of HunterdonFlemington, NJ
CLOSE  X  
Clinical Updates in Idiopatihc Pulmonary Fibrosis
Room: Hall B3, Level 3
Learning Objectives:
  1. Describe the epidemiology and pathophysiology of Idiopathic Pulmonary Fibrosis (IPF) and the importance of early diagnosis.
  2. Review the diagnosis and management of IPF recommended in the 2011 ATS/ERS guidelines.
  3. Evaluate the emerging data in IPF treatment options and the impact this information has on management approaches for existing and newly diagnosed patients with IPF.
Faculty:
  1. Kevin Flaherty, MD, Professor, Internal Medicine, University of MichiganAnn Arbor, MI, Medical Director, Idiopathic Pulmonary Fibrosis Foundation Clinical Care Site, University of MichiganAnn Arbor, MI, Associate Director, T32 Multidisciplinary Training Program in Lung Diseases, University of MichiganAnn Arbor, MI (Bio)
  2. Fernando Martinez, MD, MS, Gladys and Roland Harriman Professor of Medicine, Department of Medicine, Weill Cornell Medical CenterNew York, NY (Bio)
Primary Care Updates Track 1
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 1: Merck & Co., Inc., Amarin Pharma Inc., sanofi-aventis U.S., Forest Laboratories Inc. and Boehringer Ingelheim Pharmaceuticals, Inc.
Primary Care Updates Track 2
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 2: Sunovion Pharmaceuticals Inc., Novo Nordisk Inc. and sanofi-aventis U.S.
6:45AM
 
7:15AM
 
7:45AM
 
8:15AM
 
8:45AM
 
9:15AM
 
9:45AM
 
10:15AM
 
10:45AM
 
11:15AM
 
11:45AM
 
12:15PM
 
12:45PM
 
1:15PM
 
1:45PM
 
2:15PM
 
2:45PM
 
6:45 AM-7:35 AM - Registration & Breakfast
6:45 AM-7:35 AM - Registration & Breakfast
  
  
7:35 AM-7:45 AM - Opening Remarks
7:35 AM-7:45 AM - Opening Remarks
7:45 AM-9:00 AM
Update on Immunizations in High Risk Adults
7:45 AM-9:00 AM
New Drugs for PCP: What You Need to Know
  
  
  
  
9:00 AM-9:15 AM - AM Break
9:00 AM-9:15 AM - AM Break
9:15 AM-10:30 AM
Meeting The Challenge of Managing Lipids Beyond LDL-C
9:15 AM-10:30 AM
A Focus on Bipolar Depression: Overcoming Diagnostic Barriers and Optimizing Long-Term Patient Outcomes
  
  
  
  
10:30 AM-11:45 AM
Evolving Insulin Therapy: Optimizing Care Through Proper Selection & Use
10:30 AM-11:45 AM
Getting Your Patients to Weigh In Discussing Approaches to Treating Obesity in the Primary Care Setting
  
  
  
  
11:45 AM-12:30 PM - Lunch
11:45 AM-12:30 PM - Lunch
  
  
12:30 PM-1:45 PM
Optimizing the Diagnosis, Treatment, and Management of Irritable Bowel Syndrome
12:30 PM-1:45 PM
Migraine Headaches: Tools for Successful Management
  
  
  
  
1:45 PM-2:00 PM - PM Break
1:45 PM-2:00 PM - PM Break
2:00 PM-3:15 PM
Clinical Updates in Idiopatihc Pulmonary Fibrosis
2:00 PM-3:15 PM
Combining GLP-1 Receptor Agonists with Basal Insulin: Realizing the Potential in Type 2 Diabetes
  
  
  
  
CLOSE  X  
Registration and Refreshments
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
The Power of Lifestyle Changes, Social Networks, & Trust
Room: Hall B3, Level 3
We tend to think of advances in medicine as a new drug, laser, or surgical procedure, something high-tech and expensive. This presentation will discuss the power of comprehensive lifestyle changes, reviewing more than 30 years of research using high-tech, state-of-the-art measures to prove the power of low-tech, low-cost, and often ancient interventions. Also, the lecture will describe proven strategies for motivating people to make and maintain comprehensive lifestyle changes as well as how to personalize a way of eating and living based on an individual’s needs, genes, and preferences. Finally, the presentation will describe many of the health policy implications of comprehensive lifestyle changes as both medically effective and cost effective.
Learning Objectives:
  1. Participants will be able to understand successful strategies for motivating people to make and maintain comprehensive lifestyle changes
  2. Participants will be able to describe the evidence from randomized controlled trials showing that chronic diseases such as coronary heart disease and prostate cancer may be stopped or even reversed by making comprehensive lifestyle changes.
  3. Participants will be able to describe evidence showing that comprehensive lifestyle changes may affect gene expression.
Faculty:
  1. Dean Ornish, MD, Founder and President, Preventive Medicine Research Institute, Clinical Professor of Medicine, University of CaliforniaCardiff, CA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Hypertension Management: A Moving Target
Room: Hall B3, Level 3
Learning Objectives:
  1. Review the JNC8 guidelines for hypertension in adults, with special attention to new blood pressure goals
  2. Consider patient factors such as age, co-morbidities, and race when prescribing anti-hypertensive therapy
Faculty:
  1. Karol Watson, FACC, PhD, MD, Assistant Professor of Medicine, Division of Cardiology, Director, UCLA Center for Cholesterol and Hypertension Management, Director, UCLA Women's Cardiovascular Center, David Geffen School of Medicine at UCLALos Angeles, CA, Co-Director, Program in Preventative Cardiology, Director, Center for Cholesterol and Hypertension Management, UCLALos Angeles, CA, Director, UCLA Women's Cardiovascular Center, UCLA Los Angeles, CA (Bio)
CLOSE  X  
Testosterone Replacement Therapy for Hypogonadism: What is the Evidence? Is it Safe?
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Review role of testosterone in Men's Health
  2. Discuss the diagnosis of Hypogonadism
  3. Highlight published treatment guidelines for testosterone replacement therapy (TRT)
  4. Discuss recent data on cardiovascular risk factors for TRT
  5. Discuss the effects of TRT on the prostate in the aging male
Faculty:
  1. Culley Carson, FACS , MD, Professor and Chief, School of Medicine, Urology, University of North Carolina Chapel Hill, NC, University of North Carolina at Chapel HillChapel Hill, NC (Bio)
CLOSE  X  
The Prostate: BPH and Beyond
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Apply diagnostic and treatment strategies to men with BPH
  2. Review the AUA 2014 updated BPH guidelines
  3. Apply diagnostic and treatment strategies to men with ED
  4. Discuss the relationship between ED and cardiovascular disease
Faculty:
  1. Mohit Khera, MPH, MD, MBA, Associate Professor of Urology, Scott Department of Urology, Baylor College of MedicineHouston, TX (Bio)
CLOSE  X  
Update on the Pathophysiology of the Acute Coronary Syndromes
Room: Hall B3, Level 3
Learning Objectives:
  1. Discuss the cellular and molecular pathogenesis of acute coronary syndromes and the scientific basis of therapeutic goal of "plaque stabilization"
  2. Explain the shifts in the clinical aspects of acute coronary syndromes in the statin era and how these impact patient care
  3. Compare and contrast current and emerging therapies to prevent acute coronary syndromes
  4. Formulate treatment plans for ACS using current guidelines and best available evidence
Faculty:
  1. Peter Libby, FACC , MD, Cardiovascular Medicine, Brigham and Women's HospitalBoston, MA, Mallinckrodt Professor of Medicine, Harvard Medical SchoolBoston, MA (Bio)
CLOSE  X  
Men's Health Panel Discussion
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Review and discuss expert faculty examples from their own practices on BPH/LUTS, erectile dysfunction and testosterone replacement.
Faculty:
  1. Mohit Khera, MPH, MD, MBA, Associate Professor of Urology, Scott Department of Urology, Baylor College of MedicineHouston, TX (Bio)
CLOSE  X  
Cardiovascular Panel Discussion
Room: Hall B3, Level 3
Learning Objectives:
  1. Interpret and apply the new hypertension and cholesterol guidelines in the context of real-world patient cases
Faculty:
  1. Karol Watson, FACC, PhD, MD, Assistant Professor of Medicine, Co-Director, Lipid Clinic, UCLA Medical CenterLos Angeles, CA (Bio)
  2. Peter Libby, FACC , MD, Mallinckrodt Professor of Medicine, Harvard Medical SchoolBoston, MA, Cardiovascular Medicine, Brigham and Women's HospitalBoston, MA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Optimizing Insulin Therapy for Patients with Type 2 Diabetes: Existing Challenges and New Opportunities for Improved Care
Room: Hall B3, Level 3
Learning Objectives:
  1. Better identify and understand the pathophysiologic defects contributing to postprandial hyperglycemia and its impact on managing the glycemic burden in patients with type 2 diabetes mellitus.
  2. Incorporate assessment of postprandial glucose as part of diagnostic and treatment plan so as to target therapy to better manage hyperglycemia and prevent potential complications in patients with type 2 diabetes mellitus.
  3. Overcome both clinician and patient resistance to appropriate initiation and intensification of insulin therapy to best manage postprandial hyperglycemia, while lowering risk for adverse events.
  4. Better distinguish conventional, new, and emerging prandial insulin therapies for appropriate treatment selection in patients with T2DM so as to properly integrate in to care and improve outcomes.
Faculty:
  1. Lawrence Blonde, MD, FACP, FACE, Director, Ochsner Diabetes Clinical Research UnitNew Orleans, LA, Department of Endocrinology, Diabetes and Metabolic Diseases, Ochsner Medical CenterNew Orleans, LA (Bio)
  2. Frank Lavernia, MD, Founder, North Broward Diabetes CenterDeerfield Beach, FL (Bio)
CLOSE  X  
Diagnostic Challenges of Rheumatologic Disease
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Recognize the importance of pathophysiology in understanding rheumatic disease - target tissue and characteristic joint distribution
  2. Distinguish inflammatory from non-inflammatory (degenerative) arthritis and non-articular (soft-tissue) rheumatic conditions.
  3. Discuss the role of laboratory and imaging studies in rheumatologic diagnosis
  4. Review the features that distinguish fibromyalgia from other rheumatic diseases
Faculty:
  1. Peng Fan, FACP , MD, Clinical Professor of Medicine/Rheumatology, Medicine, David Geffen School of Medicine at UCLALos Angeles, CA (Bio)
CLOSE  X  
Eating Disorders for the Primary Care Clinician
Room: George Bush Ballroom, Level 3
This activity will provide an overview of anorexia nervosa and bulimia nervosa, focusing on epidemiology, risk factors, complications and comorbidities. The activity aims to enable the learner to identify eating disorders and common complications, and develop an initial plan of care. Learners will also be able to recognize urgent medical and psychiatric conditions that require immediate intervention.
Learning Objectives:
  1. Recognize the prevalence of disordered eating and of eating disorders in the adolescent population
  2. Define anorexia nervosa, bulimia nervosa, and other specified feeding or eating disorder using new DSM criteria
  3. List common comorbidities and complications of eating disorders
  4. Recognize medical and psychiatric findings that require urgent intervention
  5. Implement steps for identifying patients with eating disorders and design a preliminary plan of care
Faculty:
  1. Sindhu Idicula, MD, Assistant Professor of Psychiatry and Pediatrics, Menninger Department of Psychiatry, Baylor College of MedicineHouston, TX, Texas Childrens HospitalStafford, TX (Bio)
  2. Sharonda Alston-Taylor, MD, Assistant Professor, Adolescent Medicine and Sports Medicine Section, Department of Pediatrics, Baylor College of MedicineHouston, TX, Director, Teens Working on Wellness Adolescent Weight Management Clinic, Texas Childrens HospitalStafford, TX (Bio)
CLOSE  X  
Diagnosis and Management of Urinary Incontinence
Room: Hall B3, Level 3
Overactive bladder and incontinence are highly prevalent yet underreported medical conditions. This activity will review the types of incontinence and include a detailed summary of how to diagnose and treat stress and urge incontinence in both men and women including treatment for refractory disease. Both medical, surgical and new innovative treatment options will be discussed.
Learning Objectives:
  1. Apply diagnostic and treatment strategies for stress incontinence
  2. Apply diagnostic and treatment strategies for urge incontinence
  3. Evaluate effective treatment options for refractory urge and stress incontinence
Faculty:
  1. Mohit Khera, MPH, MD, MBA, Associate Professor of Urology, Scott Department of Urology, Baylor College of MedicineHouston, TX (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Primary Care Approach to Mood Disorders
Room: George Bush Ballroom, Level 3
Mood disorders are common, however they also are difficult to diagnose and distinguish. Topics to be discussed will include clinical characteristics, differential diagnosis, and impact of mood disorders, manners in which they interact with other medical disorders, and potentially useful treatments. Treatment strategies will be discussed in terms of a critical assessment of their clinical utility, their integration into medical care, and indications for referral and/or collaborative care. Both pharmacologic and non-pharmacologic strategies will be discussed.
Learning Objectives:
  1. Summarize the basic characteristics of mood disorders and their course
  2. Evaluate diagnosis and treatment strategies for depressive, manic and mixed states
  3. Apply specific strategies for the three stages of treatment throughout the time course of the illness
  4. Discuss interactions with other illnesses and review available treatment options
Faculty:
  1. Alan Swann, MD, Professor, Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of MedicineHouston, TX (Bio)
CLOSE  X  
Preventive Medicine that Works: Adult Immunization
Room: Hall B3, Level 3
Learning Objectives:
  1. Discuss the current gap between national immunization goals and current immunization rates
  2. Use the current ACIP guidelines to vaccinate adult patients
  3. Implement strategies to improve immunization rates in clinician offices
  4. Review vaccination recommendations for immune compromised patients - Cancer - Autoimmune diseases/Iatrogenic immune suppression - Immunodeficiency (Inherited, Acquired) - Transplant patients - Splenectomy, Splenic Dysfunction
Faculty:
  1. Robert Hopkins, MD, FACP, FAAP, Professor of Internal Medicine and Pediatrics, University of Arkansas for Medical Sciences College of MedicineLittle Rock, AR (Bio)
CLOSE  X  
Review and Update of Drug Therapy for Major Depressive Disorder
Room: George Bush Ballroom, Level 3
This lecture will provide an overview of recent developments in the treatment of major depressive disorder. The lecture will summarize current antidepressant medication options, and discuss augmentation strategies for patients with difficult-to-treat depression. Safety and efficacy information will be reviewed for several of the new FDA-approved medications for major depressive disorder.
Learning Objectives:
  1. Review the pharmacological treatment strategies for patients with major depressive disorder who inadequately respond to antidepressant therapy
  2. Explain the importance of treating depressive episodes to full remission
  3. Analyze the safety and efficacy data for recent FDA approved antidepressants
Faculty:
  1. Sanjay Mathew, MD, Staff Physician, Michael E. DeBakey Veteran Affairs Medical CenterHouston, TX, Majorie Bintliff Johnson and raleigh White Johnson, Jr. Chair for Research in Ps, Menninger Department of Psychiatry & Behavioral Sciences, Associate Professor of Psychiatry & Behavioral Sciences, Baylor College of MedicineHouston, TX (Bio)
CLOSE  X  
Controversies in Osteoporosis Prevention and Management
Room: Hall B3, Level 3
Learning Objectives:
  1. Review the guidelines and controversies regarding screening and benefits and adverse effects of therapy
  2. Discuss the controversies regarding duration of therapy and monitoring of therapy
Faculty:
  1. Carolyn Crandall, MD, Professor of Medicine, Iris Cantor-UCLA Women’s Health Center, David Geffen School of Medicine at UCLALos Angeles, CA (Bio)
6:45AM
 
7:15AM
 
7:45AM
 
8:15AM
 
8:45AM
 
9:15AM
 
9:45AM
 
10:15AM
 
10:45AM
 
11:15AM
 
11:45AM
 
12:15PM
 
12:45PM
 
1:15PM
 
1:45PM
 
2:15PM
 
2:45PM
 
3:15PM
 
3:45PM
 
4:15PM
 
4:45PM
 
5:15PM
 
5:45PM
 
6:45 AM-7:30 AM - Registration and Refreshments
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
The Power of Lifestyle Changes, Social Networks, & Trust
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-10:30 AM
Hypertension Management: A Moving Target
9:45 AM-10:30 AM
Testosterone Replacement Therapy for Hypogonadism: What is the Evidence? Is it Safe?
 
 
10:30 AM-11:15 AM
Update on the Pathophysiology of the Acute Coronary Syndromes
10:30 AM-11:15 AM
The Prostate: BPH and Beyond
 
 
11:15 AM-11:30 AM
Cardiovascular Panel Discussion
11:15 AM-11:30 AM
Men's Health Panel Discussion
11:30 AM-1:00 PM - Networking Break and Additional Opportunities
 
 
 
 
 
1:00 PM-2:15 PM
*Optimizing Insulin Therapy for Patients with Type 2 Diabetes: Existing Challenges and New Opportunities for Improved Care
1:00 PM-2:15 PM
Diagnostic Challenges of Rheumatologic Disease
 
 
 
 
2:15 PM-3:00 PM
Diagnosis and Management of Urinary Incontinence
2:15 PM-3:00 PM
Eating Disorders for the Primary Care Clinician
 
 
3:00 PM-4:00 PM - Networking Break and Additional Opportunities
 
 
 
4:00 PM-5:00 PM
Preventive Medicine that Works: Adult Immunization
4:00 PM-5:00 PM
Primary Care Approach to Mood Disorders
 
 
 
5:00 PM-6:00 PM
Controversies in Osteoporosis Prevention and Management
5:00 PM-6:00 PM
Review and Update of Drug Therapy for Major Depressive Disorder
 
 
 
*To date, Primary Care Updates has been supported by educational grants from the following organizations: sanofi-aventis U.S.
CLOSE  X  
Registration and Refreshments
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
Dharma Happiness and Purpose
Room: Hall B3, Level 3
Dr. Sanjiv Chopra will define Dharma . Reflect on the research regarding Happiness and tell us how we can be happier and live a joy - filled life . He will share compelling stories and wisdom about how living with purpose is the key to sustained happiness. As Mark Twain once said, "The two most important days of your life are the day you are born the day you find out why." This talk will speak to your heart and inspire you to lead a happier and meaningful life.
Learning Objectives:
  1. Recognize that they key to sustained happiness is living with purpose
  2. Identify four traits of happy individuals
  3. Recall the "happiness formula" and list the 6 "happiness countries"
Faculty:
  1. Sanjiv Chopra, MD, MACP, Senior Consultant in Hepatology, Beth Israel Deaconess Medical CenterBoston, MA, Professor of Medicine, Harvard Medical SchoolBoston, MA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Spotlight on Hepatitis C Infection
Room: Hall B3, Level 3
Learning Objectives:
  1. Outline epidemiology and risk factors for chronic hepatitis C
  2. Review the natural history and the clinical impact of chronic hepatitis C infection
  3. Discuss current treatment options for chronic hepatitis C infection
Faculty:
  1. Sammy Saab, MD, MPH, AGAF, Associate Professor of Medicine and Surgery, David Geffen School of Medicine at UCLALos Angeles, CA (Bio)
CLOSE  X  
New Approaches to Treating C Difficile Infection
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Distinguish risk factors for C. difficile infection (CDI) in an outpatient with recent diarrheal symptoms
  2. Consider the pros and cons of treatment modalities
  3. Employ prevention measures for clinicians, patients, and households
Faculty:
  1. Kalpana Gupta, MD, MPH, Associate Professor of Medicine, Boston University School of MedicineBoston, MA, Chief, Section of Infectious Diseases, VA Boston Healthcare System Boston, MA (Bio)
CLOSE  X  
A Tale of Two Brains
Room: Hall B3, Level 3
Learning Objectives:
  1. Review the differences between right- and left-brain mode of engagement
  2. Apply methods to rekindle a right-brain worldview
  3. Discuss why a right-brain mode may actually be beneficial for a physician
  4. List the many physical findings that were first observed by artists
Faculty:
  1. Salvatore Mangione, MD, Associate Professor of Medicine, Jefferson Medical CollegePhiladelphia, PA (Bio)
CLOSE  X  
Clinical Practice Guidelines for the Management of Thyroid Disorders
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Utilize clinical practice guidelines to diagnose and manage thyroid nodules
  2. Utilize clinical practice guidelines to diagnose and manage hypothyroidism
  3. Utilize clinical practice guidelines to diagnose and manage hyperthyroidism
Faculty:
  1. Gregory Brent, MD, Professor, Medicine and Physiology, David Geffen School of Medicine at UCLALos Angeles, CA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Virtual Clinical Coffee Break: Advances and Options in Female Contraception
Room: Hall B3, Level 3
Learning Objectives:
  1. Become familiar with the newest contraceptive options available
  2. Understand how a patient’s medical background affects recommended choice of contraceptive
Faculty:
  1. Pelin Batur, MD, FACP , NCMP , CCD, Deputy Editor, Cleveland Clinic Journal of Medicine, Cleveland ClinicCleveland, OH, Education Director, Internal Medicine and Women's Health, Cleveland ClinicCleveland, OH (Bio)
CLOSE  X  
Virtual Clinical Coffee Break: Practical Tips for the Management of ADHD
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Identify the core symptoms of ADHD
  2. Consider patient factors and the pros and cons of ADHD drugs when selecting treatment
Faculty:
  1. Thomas Cummins, MD, Assistant Professor, Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of MedicineChicago, IL (Bio)
CLOSE  X  
Walking the Line: A Primer on Gait Analysis
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Incorporate gait evaluation in determining fall risk in elderly patients
  2. Recognize gaits that are associated with common musculoskeletal conditions
  3. Recognize gaits that are associated with common neurological conditions
  4. Link gait abnormalities to historical figures and celebrities
Faculty:
  1. Salvatore Mangione, MD, Associate Professor of Medicine, Jefferson Medical CollegePhiladelphia, PA (Bio)
CLOSE  X  
Ebola Update
Room: Hall B3, Level 3
Learning Objectives:
  1. Identify epidemiological risk factors for Ebola Virus Disease
  2. Recognize clinical features of Ebola Virus Disease
  3. Employ measures for prevention of the spread of Ebola Virus Disease
Faculty:
  1. Kalpana Gupta, MD, MPH, Associate Professor of Medicine, Boston University School of MedicineBoston, MA, Chief, Section of Infectious Diseases, VA Boston Healthcare System Boston, MA (Bio)
CLOSE  X  
Cascade Effects in Primary Care Medicine
Room: Hall B3, Level 3
Learning Objectives:
  1. Define and describe cascade effects using case examples
  2. Describe the implications of cascade effects in primary care medicine
  3. Discuss three different communication and decision making techniques to help "break" cascade momentum
Faculty:
  1. Courtenay Bruce, JD, MA, Assistant Professor of Medicine & Medical Ethics, Center for Medical Ethics & Health Policy, Baylor University College of MedicineHouston, TX (Bio)
"Cascade effects" is a term in decision psychology that refers to a process that, once initiated, continues to lead to a chain of events that snowball and cannot easily be stopped until the case concludes. The trigger often occurs in primary care medicine, but it is not typically recognized by participants. This talk will describe the concept and its implications in primary care, and we will discuss different communication and decision making techniques to help "break" cascade momentum.
CLOSE  X  
Therapeutic Considerations for the Management of Childhood Obesity
Room: George Bush Ballroom, Level 3
The rate of childhood obesity has reached almost epidemic proportions in the recent years. Dr. O’Connor will review the current guidelines from health organizations, such as the American Academy of Pediatrics and the American Heart Association, regarding screening, assessments and recommendations for lifestyle behaviors associated with childhood obesity and appropriate screening for obesity-related medical conditions among youth. She will discuss evidence- based behavioral change strategies for the prevention and treatment of overweight and obesity that can be employed in pediatric primary care clinics.
Learning Objectives:
  1. Identify appropriate laboratory screening of obesity-related medical conditions among overweight or obese youth
  2. List current recommendations for lifestyle behavior change to prevent or treat childhood obesity
  3. Recognize at least two behavior change strategies appropriate for families that can be promoted in pediatric clinical settings
Faculty:
  1. Teresia O'Connor, MD, MPH, Assistant Professor, Nutrition; and Academic General Pediatrics, USDA/ARS Children’s Nutrition Research Center, Department of Pediatrics, Baylor College of MedicineHouston, TX, General Pediatrics, Texas Childrens HospitalStafford, TX (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Recommendations for Assessing and Treating Irritable Bowel Syndrome
Room: Hall B3, Level 3
Irritable bowel syndrome (IBS) is the most common GI disorder seen in outpatient practice. Most patients with IBS do not receive a positive IBS diagnosis. While the underlying etiology remains unclear and probably multifactorial, there has been considerable progress in the understanding of this disease. This activity will review the recent theories about IBS and discuss them in relation to diagnosis and treatment. Dr. El-Serag will also review the recent medical and psychological treatments available for IBS.
Learning Objectives:
  1. Effectively diagnose irritable bowel syndrome (IBS)
  2. Describe the most recent theories of IBS pathogenesis and their relevance to the diagnosis and treatment
  3. Review the recent advances in pharmacological and non-pharmacological treatments for IBS
Faculty:
  1. Hashem El-Serag, MD, MPH, Chief, Section of Gastroenterology and Hepatology, Baylor College of MedicineHouston, TX (Bio)
CLOSE  X  
Screening Guidelines for Men's Health
Room: George Bush Ballroom, Level 3
This activity is a review of the updates for the latest screening guidelines in the field of colon, prostate and lung cancer. The merits of screening and the frequency of screening will be discussed in addition to the process of shared decision making.
Learning Objectives:
  1. Review current updates in screening guidelines for prostate cancer, lung cancer, and colon cancer
  2. Justify the merits for and frequency of cancer screening on a patient to patient basis
  3. Implement Shared Decision Making in screening
Faculty:
  1. Radha Rao, MD, Assistant Professor, Internal Medicine, Baylor College of MedicineHouston, TX, Staff Physician, Michael E. DeBakey Veteran Affairs Medical CenterHouston, TX (Bio)
CLOSE  X  
Advances in Managing COPD Patients
Room: George Bush Ballroom, Level 3
COPD is a major public health problem with significant morbidity and mortality. Several new developments have occurred in this disease that led to our better understanding of its pathophysiology and management. This activity will outline latest advances in this disease including screening and diagnosis criteria and will discuss the treatment and management options for COPD in a primary care setting.
Learning Objectives:
  1. Discuss the impact of COPD
  2. Review the pathophysiology of COPD
  3. Outline guidelines’ recommendations for assessment of COPD
  4. Discuss non-pharmacologic and pharmacologic management strategies of COPD
Faculty:
  1. Nicola Hanania, MD, FCCP, FRCP, FACP, Associate Professor of Medicine, Section of Pulmonary and Critical Care Medicine, Director, Asthma Clinical Research Center, Baylor College of MedicineHouston, TX (Bio)
CLOSE  X  
Diagnosis and Treatment of Gallstone Diseases
Room: Hall B3, Level 3
This activity will discuss the common risk factors and presenting signs/symptoms of gallstone related diseases. Dr. Patel will outline a practical clinical approach to diagnosing specific gallstone conditions. He will also discuss appropriate management of specific gallstone related diseases including biliary colic, cholangitis, and pancreatitis. Finally, the role of the primary care provider in the management of gallstone diseases and that of various specialists will be reviewed.
Learning Objectives:
  1. Identify the risk factors and predisposing conditions associated with gallstone formation
  2. Diagnose gallstone related conditions accurately
  3. Evaluate effective treatment of certain gallstone diseases
Faculty:
  1. Kalpesh Patel, MD, Assistant Professor of Medicine, Gastroenterology & Hepatology, Baylor College of MedicineHouston, TX (Bio)
6:45AM
 
7:15AM
 
7:45AM
 
8:15AM
 
8:45AM
 
9:15AM
 
9:45AM
 
10:15AM
 
10:45AM
 
11:15AM
 
11:45AM
 
12:15PM
 
12:45PM
 
1:15PM
 
1:45PM
 
2:15PM
 
2:45PM
 
3:15PM
 
3:45PM
 
4:15PM
 
4:45PM
 
5:15PM
 
6:45 AM-7:30 AM - Registration and Refreshments
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
Dharma Happiness and Purpose
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-10:45 AM
Spotlight on Hepatitis C Infection
9:45 AM-10:45 AM
New Approaches to Treating C Difficile Infection
 
 
 
10:45 AM-11:45 AM
A Tale of Two Brains
10:45 AM-11:45 AM
Clinical Practice Guidelines for the Management of Thyroid Disorders
 
 
 
11:45 AM-1:00 PM - Networking Break and Additional Opportunities
 
 
 
 
1:00 PM-1:30 PM - Virtual Clinical Coffee Break: Advances and Options in Female Contraception
1:00 PM-1:30 PM - Virtual Clinical Coffee Break: Practical Tips for the Management of ADHD
 
1:30 PM-2:00 PM
Ebola Update
1:30 PM-2:00 PM
Walking the Line: A Primer on Gait Analysis
 
2:00 PM-2:45 PM
Cascade Effects in Primary Care Medicine
2:00 PM-2:45 PM
Therapeutic Considerations for the Management of Childhood Obesity
 
 
2:45 PM-3:45 PM - Networking Break and Additional Opportunities
 
 
 
3:45 PM-4:45 PM
Recommendations for Assessing and Treating Irritable Bowel Syndrome
3:45 PM-4:45 PM
Screening Guidelines for Men's Health
 
 
 
4:45 PM-5:30 PM
Diagnosis and Treatment of Gallstone Diseases
4:45 PM-5:30 PM
Advances in Managing COPD Patients
 
 

Ticketed Events

Morning Additional Opportunities and Networking Break

Non-CME Presentation Theater

8:55 AM-9:40 AM

Pneumococcal Disease

8:55 AM-9:40 AM

HEP-C

8:55 AM-9:40 AM

Gastro

8:55 AM-9:40 AM

Lipids

Additional Opportunities and Networking Break

Additional Opportunities and Networking Break

CME Educational Symposia

11:40 AM-12:55 PM

Coronary Heart Disease

Non-CME Presentation Theater

12:00 PM-12:45 PM

Diabetes

12:00 PM-12:45 PM

Orthopedics

12:00 PM-12:45 PM

Hep-B

Afternoon Additional Opportunities and Networking Break

Non-CME Presentation Theater

3:10 PM-3:55 PM

Atrial Fibrillation / Stroke

3:10 PM-3:55 PM

Heart Failure

3:10 PM-3:55 PM

Hepatitis C

Morning Additional Opportunities and Networking Break

Non-CME Presentation Theater

8:55 AM-9:40 AM

Residual Cardiovascular Risk

8:55 AM-9:40 AM

Probiotics

8:55 AM-9:40 AM

Type 2 Diabetes

8:55 AM-9:40 AM

PCSK9 in Cholesterol Homeostasis

Additional Opportunities and Networking Break

Non-CME Presentation Theater

12:00 PM-12:45 PM

Medical Mystery

12:00 PM-12:45 PM

Exocrine Pancreatic Insufficiency

12:00 PM-12:45 PM

Type 2 Diabetes

Afternooon Additional Opportunities and Networking Break

Non-CME Presentation Theater

2:55 PM-3:40 PM

Obesity

2:55 PM-3:40 PM

Cardiovascular Disease

2:55 PM-3:40 PM

Major Depressive Disorder

CLOSE  X  
Pneumococcal Pneumonia and Invasive Disease in Adults: Help Protect Patients Aged 65+ in Your Practice
Room: Theater 1
Faculty:
  1. Vincent Valentine, MD
CLOSE  X  
HARVONI: Changing what is possible with a simple treatment regimen
Room: Theater 2
Faculty:
  1. Imtiaz Alam
CLOSE  X  
Hepatic Encephalopathy: Understanding the CNS Dysfunction as a Result of Cirrhosis
Room: Room 310
Faculty:
  1. Steven Flamm, MD
CLOSE  X  
Advancing Knowledge of Hypertriglyceridemia
Room: Room 320C
CLOSE  X  
Latest Advances in Secondary Prevention of Cardiovascular Events
Room: Ballroom C, Level 3
Learning Objectives:
  1. Review the 2011 ACC/AHA Secondary Prevention Guideline recommendations.
  2. Discuss the implications for secondary prevention of the 2013 ACC/AHA lipid guideline and the updated hypertension recommendations.
  3. Evaluate the implications of the latest trial results for lipid management in secondary prevention.
  4. Place newly approved anti-platelet agents into perspective for the management of secondary prevention post-Acute Coronary Syndrome and for patients with peripheral artery disease based on emerging evidence.
Faculty:
  1. Peter Libby, FACC , MD, Cardiovascular Medicine, Brigham and Women's HospitalBoston, MA, Mallinckrodt Professor of Medicine, Harvard Medical SchoolBoston, MA (Bio)
The CME activity is supported by an educational grant from Merck & Co., Inc..
CLOSE  X  
The Effect of a Once-Weekly Therapy on A1C and Weight Over 3 Years
Room: Theater 2
Faculty:
  1. Bradley Wallum, MD
CLOSE  X  
Understanding Dupuytren's Contracture: Disease Awareness for the General Practitioner. Indication: XIAFLEX® is indicated for the treatment of adult patients with Dupuytren's contracture with a palpable cord
Room: Room 320C
Faculty:
  1. David Friedman, MD
CLOSE  X  
An Introduction to Chronic Hepatitis B - Partnering to Act on Hepatitis B Virus in Your Community.
Room: Theater 1
Faculty:
  1. Enrique Martinez, MD, FACP
CLOSE  X  
A Paradigm Shift In The Treatment of Thrombosis
Room: Theater 1
Faculty:
  1. Steven Deitelzweig, MD
CLOSE  X  
A Change of Heart - Achieving Best Outcomes When Caring for African American HF Patients
Room: Room 310
Faculty:
  1. Phillip Duncan, FACC, MD
CLOSE  X  
Curing Chronic HCV
Room: Theater 2
CLOSE  X  
TBD
Room: Theater 1
CLOSE  X  
Expert Views: Demystifying Probiotics
Room: Room 310
CLOSE  X  
Supporting Nurse Practitioners and Physician Assistants in Diabetes Care: Targeting the Kidney in Type 2 Diabetes
Room: Room 320 C
Faculty:
  1. Virginia Valentine, BC-ADM, CDE, APRN
CLOSE  X  
The Prevalence of Dyslipidemia in Diabetes: Cholesterol Management and the Role of PCSK9 in Cholesterol Homeostasis
Room: Theater 2
CLOSE  X  
Medical Mystery: A Case of Unexplained Recurrent Abdominal Pain
Room: Room 310
Faculty:
  1. William Lumry, MD, FACP, FAAAAI (Bio)
CLOSE  X  
Understanding the Data on EPI (Exocrine Pancreatic Insufficiency)
Room: Theater 2
CLOSE  X  
An Individualized Approach to the Treatment of Adults with Type 2 Diabetes
Room: Theater 1
This program will cover the following topics regarding a sodium-glucose co-transporter (SGLT2) inhibitor: the role of the kidney in regulation of hyperglycemia in T2DM, the mechanism of action – mediated inhibition of SGLT2 in the proximal convoluted tubule of the kidney, key efficacy and safety data from active-controlled clinical trials, Important Safety Information, question and answer session. This promotional educational activity is sponsored by Janssen Pharmaceuticals, Inc. It is not certified for continuing medical education.
Faculty:
  1. Charles Reasner, MD, II
CLOSE  X  
Addressing Chronic Weight Management With Targeted Pharmacotherapy
Room: Theater 1
Faculty:
  1. Gregory Phillips, MD
CLOSE  X  
Discussion of an Anticoagulant for Treatment of Nonvalvular Atrial Fibrillation and Venous Thromboembolism
Room: Room 310
This presentation will focus on the introduction of an oral anticoagulation treatment option. During the program, you will learn about the treatment’s clinical profile and will be able to review important clinical considerations. Topics that will be discussed include key results from pivotal NVAF and VTE trials, recommended dosing and administration, and highlights of key safety information, including adverse events and boxed warnings.
Faculty:
  1. Jaime Burkle, MD, FACC
CLOSE  X  
Breaking Through the Frustration of Major Depressive Disorder [MDD]: Understanding the Disease and Improving Treatment Outcomes
Room: Theater 2

Accreditation

Earn up to 19.5 AMA PRA Category 1 Credits™ or 19.5 AANP contact hours of continuing education.

Final session schedule is pending. Credits estimated based on current schedule.

Primary Care Updates
March 12, 2015
Credits Type Accreditation Statement Designation Statement
6.25 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.25 AAFP This live activity, Southwest Annual Conference, with a begin date of 3/12/2015-3/14/2015, has been reviewed and is acceptable for up to 6.25 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.25 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.25 contact hours of continuing education (which includes 3.250 hours of pharmacology).
Annual Conference
March 13–14, 2015
Credits Type Accreditation Statement Designation Statement
13.25 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
13.25 AAFP This live activity, Southwest Annual Conference, with a begin date of 3/12/2015-3/14/2015, has been reviewed and is acceptable for up to 13.25 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
13.25 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 13.25 contact hours of continuing education (which includes 6.750 hours of pharmacology).

Keynote Speakers

Dean Ornish, MD (Read Bio)

Preventive Medicine Research Institute,
University of California, Cardiff, CA

Presenting on:

Sanjiv Chopra, MD, MACP (Read Bio)

Beth Israel Deaconess Medical Center, Boston, MA
Harvard Medical School, Boston, MA

Presenting on:

Exhibit Hall

Pri-Med Exhibit Hall

Hours
Friday, March 13 8:30am–4pm
Saturday, March 14 8:30am–4pm

The Pri-Med Exhibit Hall is your chance to learn about and compare hundreds of the health care industry’s latest products, treatments, and technologies in one place.


Spend your time in the Exhibit Hall talking to company representatives, evaluating new options, and making purchasing decisions for your practice—all things you do not have time for in your daily schedule. 

Attendee Badge Information

Please Note: As a Pri-Med attendee, you will receive a badge and an Attendance Scan Card, which will have a QR code programmed with your name, address, and professional discipline. You will scan your bar code at the appropriate stations to obtain CME credit or nursing contact hours. You will need to scan your badge once per day to receive CME credit for the Annual Conference and at the entrances to some stand-alone CME activities to be eligible for CME credit or nursing contact hours.

Scanning your QR code at an exhibit booth or non-CME activity gives the sponsor permission to use your contact information for future correspondence.

 

Exhibit Floor Highlights

Presentation Theaters
Join us for an informative snack break, lunch, or dinner discussion about the latest clinical information as it relates to a specific disease state.

Pri-Med Recharge Lounge
Relax. Recharge. Refuel. Visit this booth for complimentary coffee and small snacks during some of the break times.

Pri-Med Booth
Stop by the Pri-Med Booth to have any questions answered, update your contact information, find out about online resources and tools, and register for Pri-Med Southwest 2016.

InLight
Created by Pri-Med and the developers of Amazing Charts, InLight EHR is the first problem-oriented medical record, supporting better medical decision-making and more face-to-face time with patients. Stop by the InLight booth for a demo of the EHR that learns with you!

Amazing Charts
Amazing Charts is the top rated EHR according to multiple user satisfaction surveys and is 2014 ONC-ATCB certified, easy to use, and affordable. Unlike most EHRs, Amazing Charts was designed by a physician, allowing you to document more with fewer clicks.

Stop by the Amazing Charts booth to download a FREE trial and ask about our show special!

Exhibitor List

Company Name Booth Number
AbbVie 417
Amarin Pharma, Inc. 123
American College of Physicians 208
AMGEN 508
Bionix Medical Technologies 505
Calmoseptine, Inc. 110
Cell Science Systems/ ALCAT 218
Complete Medical Services 326
Daiichi Sankyo, Inc. 137
Elsevier 104
Enovative Technologies 643
GenoVive Weight Management 418
Gilead Sciences 101
GlaxoSmithKline 119
HAE: Learn About It, Talk About It 212
Infinite Therapeutics 637
Kareo 223
Life Extension 612
Maico Diagnostics 217
Merck 403
Mission Pharmacal Co 112
Neilmed Pharmaceuticals, Inc. 216
Otto Trading, Inc. 623
Pfizer Inc. 408
Pri-Med InLight EHR 302
Qiagen, Inc. 317
Salix Pharmaceuticals, Inc. 500
Sanofi Pasteur Inc. 422
Shire U.S. Inc. 227
Surgeons Practice Solution 438
Thoughtswift 126
Unicity International 427
VIVUS, Inc 430
Whitaker Medical 523
Company Name Booth Number
Akrimax Pharmaceuticals LLC 519
Amazing Charts 203
American Express Open 100
Arbor Pharmaceuticals, Inc. 424
Bluejay Pharmacy, LLC 521
CardioDX, Inc. 113
Christus Health 538
CryoProbe 117
Eisai, Inc. 109
Endo Pharmaceuticals Inc. 331
Galderma Laboratories LP 323
Gensco Laboratories 504
Gilead Sciences 102
Grifols USA, Inc. 517
Hemosure 525
Janssen Pharmaceuticals, Inc. 209
Laclede Inc 503
Lippincott Williams & Wilkins 108
Memorial MRI & Diagnostic 222
Micro Direct, Inc. 416
Monthly Prescribing Reference 610
Orasure Technologies, Inc. 520
P&G Healthcare 319
Pri-Med 301
Pri-Med Recharge Lounge 423
Quest Diagnostics Incorporated 219
Sanofi 325
Shader Productions 627
Summit Doppler Systems 608
The Gideons International 625
Ultimate Creations 617
US Army Medicine Civilian Corps 401
Western Systems Research 501
Xenna Corp. 220
Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

George R. Brown Convention Center
1001 Avenida de las Americas
Houston, TX 77010-6032
(800) 427-4697

Hotel Accommodations

Untitled Document
Parking Map—Convention Center Area »


Convention Center Navigation Tips

Houston’s Convention District and the George R. Brown Convention Center are currently undergoing construction. We have assembled some insider tips for easy navigation to the conference:
  1. Plan for extra time in the morning to navigate the surrounding Convention District area.
  2. Avenida de las Americas, which runs across the front of the George R. Brown, is now a one-way street going south bound.
  3. A key part of the transformation of Avenida de las Americas is the partial closure of the boulevard to create a walkable plaza. Please use the marked pedestrian pathways for safe access to the George R. Brown Convention Center.
  4. Upon arrival to the Convention Center, please enter the building through Hall B on the street level. All of the conference will be held on Level 3.

Good Health Begins Here

Untitled Document

As a practicing clinician, you are the focal point of all we do. This year’s Annual Conference theme, Good Health Begins Here, not only affords you the opportunity to take away key tips to improve the health and wellness of your patient population, but also encompasses many easy ways that you can improve your own health and wellness.

We believe good health begins with you, the clinician. You are setting the precedent and we’re here to help.

Good Health Begins Here

Steps to Success & Wellness Walk

Wellness Walk: taking place on Saturday morning to start your day off on the right foot.

• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •

Steps to Success: Pri-Med is committed to helping improve your health and wellness, so we’re covering part of the cost of your activity tracker. Purchase yours and participate in the Steps to Success community. Prizes will be awarded throughout the walking challenge.

fitbit
You are eligible for one of the following products at a preferred rate:
  • Fitbit Zip: Your Price $30 | Retail Price: $59.95
  • Fitbit One: Your Price $59.50 | Retail Price: $99.95
  • Fitbit Flex: Your Price $59.50 | Retail Price: $99.95
  • Fitbit Charge: Your Price $82.75 | Retail Price: $129.95
  • Fitbit Charge HR: Your Price $102 | Retail Price: $149.95
  • Fitbit Surge: Your Price $179 | Retail Price: $249.95

A $150 AMEX gift card will be raffled off on the last Thursday of every month until May 2015 to a random participant. We’ll also be raffling off an additional gift card to a participant during the Annual Conference. Winners are selected at random and will be notified via the email in their Fitbit profile.

Take these steps to redeem your Fitbit at a preferred price:
  1. Register for Pri-Med Southwest.
  2. During the Registration Process while building your itinerary, select the option for the Fitbit Challenge | Steps to Success.
  3. We’ll contact you with all the information you need to know!
Already have a Fitbit and want to participate? No problem! We want all our attendees to participate. During the registration process, simply select the option for “I have a Fitbit, but I want to join Steps to Success.”


CME: Keynotes

Three renowned keynote speakers including Dean Ornish, MD, presenting on “The Power of Lifestyle Changes, Social Networks, & Trust”

Dr. Ornish will discuss the power of comprehensive lifestyle changes, proven strategies for motivating people to make and maintain these changes, as well as how to personalize a way of eating and living based on an individual’s needs, genes, and preferences. Finally, the presentation will describe many of the health policy implications of comprehensive lifestyle changes as both medically effective and cost effective.

 

Exhibit Hall

Health and wellness book signings and meet-the-author opportunities.